These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34133256)

  • 1. Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review.
    Hernández-Aguilar AI; Luciano-Villa CA; Tello-Flores VA; Beltrán-Anaya FO; Zubillaga-Guerrero MI; Flores-Alfaro E
    Expert Rev Mol Diagn; 2021 Aug; 21(8):809-821. PubMed ID: 34133256
    [No Abstract]   [Full Text] [Related]  

  • 2. The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases.
    Busscher D; Boon RA; Juni RP
    Clin Sci (Lond); 2022 Aug; 136(15):1157-1178. PubMed ID: 35946958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA H19 in the liver-gut axis: A diagnostic marker and therapeutic target for liver diseases.
    Li X; Liu R
    Exp Mol Pathol; 2020 Aug; 115():104472. PubMed ID: 32454104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNAs in the Pathogenesis of Insulin Resistance.
    Yang W; Lyu Y; Xiang R; Yang J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances of LncRNA H19 in Diabetes LncRNA H19 in Diabetes.
    Bi Y; Wang Y; Sun X
    Horm Metab Res; 2022 Apr; 54(4):212-219. PubMed ID: 35413741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia.
    Zhang N; Geng T; Wang Z; Zhang R; Cao T; Camporez JP; Cai SY; Liu Y; Dandolo L; Shulman GI; Carmichael GG; Taylor HS; Huang Y
    JCI Insight; 2018 May; 3(10):. PubMed ID: 29769440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review).
    Xin W; Wang Y; Hua K; Liu S
    Int J Mol Med; 2023 Aug; 52(2):. PubMed ID: 37449492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications.
    Zhu L; Li Y; Xia F; Xue M; Wang Y; Jia D; Gao Y; Li L; Shi Y; Chen S; Xu G; Yuan C
    Curr Pharm Des; 2022; 28(12):1011-1018. PubMed ID: 34895118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Functions of Long Non-Coding RNA (lncRNA) H19 in the Heart.
    Wang Y; Sun X; Sun X
    Heart Lung Circ; 2022 Mar; 31(3):341-349. PubMed ID: 34840062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting long non-coding RNA H19 as a therapeutic strategy for liver disease.
    Shi Y; Qu F; Zeng S; Wang X; Liu Y; Zhang Q; Yuan D; Yuan C
    Prog Biophys Mol Biol; 2024 Dec; 194():1-9. PubMed ID: 39357625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNAs in cardiometabolic disorders.
    Juni RP; 't Hart KC; Houtkooper RH; Boon RA
    FEBS Lett; 2022 Jun; 596(11):1367-1387. PubMed ID: 35531641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA H19 promotes vascular remodeling by sponging let-7a to upregulate the expression of cyclin D1.
    Sun W; Lv J; Duan L; Lin R; Li Y; Li S; Fu C; Zhao L; Xin S
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1038-1042. PubMed ID: 30551879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANRIL, H19 and TUG1: a review about critical long non-coding RNAs in cardiovascular diseases.
    da Cunha Agostini L; Almeida TC; da Silva GN
    Mol Biol Rep; 2023 Dec; 51(1):31. PubMed ID: 38155319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases.
    Yang Z; Zhang T; Han S; Kusumanchi P; Huda N; Jiang Y; Liangpunsakul S
    Transl Res; 2021 Apr; 230():139-150. PubMed ID: 33227504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA H19: a novel player in the regulation of diabetic kidney disease.
    Wu Q; Huang F
    Front Endocrinol (Lausanne); 2023; 14():1238981. PubMed ID: 37964955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
    Yang JJ; She Q; Yang Y; Tao H; Li J
    Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1.
    Gui W; Zhu WF; Zhu Y; Tang S; Zheng F; Yin X; Lin X; Li H
    Cell Commun Signal; 2020 Oct; 18(1):173. PubMed ID: 33115498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Coding RNAs as Potential Novel Biomarkers for Early Diagnosis of Hepatic Insulin Resistance.
    Pielok A; Marycz K
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA H19 rs4929984 Variant is Associated with Coronary Artery Disease Susceptibility in Han Chinese Female Population.
    Huang J; Li M; Li J; Liang B; Chen Z; Yang J; Guo X; Huang S; Gu L; Su L
    Biochem Genet; 2021 Dec; 59(6):1359-1380. PubMed ID: 33826032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of lncRNA H19 in fibrosis and its potential as novel therapeutic target.
    Jiang X; Ning Q
    Mech Ageing Dev; 2020 Jun; 188():111243. PubMed ID: 32298666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.